vs
Heritage Insurance Holdings, Inc.（HRTG）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Heritage Insurance Holdings, Inc.的1.0倍（$219.9M vs $215.3M），Heritage Insurance Holdings, Inc.净利率更高（31.0% vs -1.0%，领先32.0%），Heritage Insurance Holdings, Inc.同比增速更快（2.4% vs 2.0%），Heritage Insurance Holdings, Inc.自由现金流更多（$174.2M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 6.1%）
该公司是一家位于美国佛罗里达州的财产意外保险公司，在美国多个沿海州开展业务，主要为客户提供商业保险、住宅保险、房主保险以及洪水保险等各类财产意外保障产品。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HRTG vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.0倍
$215.3M
营收增速更快
HRTG
高出0.4%
2.0%
净利率更高
HRTG
高出32.0%
-1.0%
自由现金流更多
HRTG
多$157.3M
$16.8M
两年增速更快
OFIX
近两年复合增速
6.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $215.3M | $219.9M |
| 净利润 | $66.7M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 41.6% | 0.2% |
| 净利率 | 31.0% | -1.0% |
| 营收同比 | 2.4% | 2.0% |
| 净利润同比 | 228.6% | 92.4% |
| 每股收益（稀释后） | $2.15 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRTGOFIX
| Q4 25 | $215.3M | $219.9M | ||
| Q3 25 | $212.5M | $205.6M | ||
| Q2 25 | $208.0M | $203.1M | ||
| Q1 25 | $211.5M | $193.6M | ||
| Q4 24 | $210.3M | $215.7M | ||
| Q3 24 | $211.8M | $196.6M | ||
| Q2 24 | $203.6M | $198.6M | ||
| Q1 24 | $191.3M | $188.6M |
净利润HRTGOFIX
| Q4 25 | $66.7M | $-2.2M | ||
| Q3 25 | $50.4M | $-22.8M | ||
| Q2 25 | $48.0M | $-14.1M | ||
| Q1 25 | $30.5M | $-53.1M | ||
| Q4 24 | $20.3M | $-29.1M | ||
| Q3 24 | $8.2M | $-27.4M | ||
| Q2 24 | $18.9M | $-33.4M | ||
| Q1 24 | $14.2M | $-36.0M |
毛利率HRTGOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率HRTGOFIX
| Q4 25 | 41.6% | 0.2% | ||
| Q3 25 | 33.0% | -8.3% | ||
| Q2 25 | 31.2% | -7.9% | ||
| Q1 25 | 20.1% | -25.2% | ||
| Q4 24 | 15.0% | -5.3% | ||
| Q3 24 | 5.5% | -9.6% | ||
| Q2 24 | 13.6% | -12.5% | ||
| Q1 24 | 11.9% | -15.6% |
净利率HRTGOFIX
| Q4 25 | 31.0% | -1.0% | ||
| Q3 25 | 23.7% | -11.1% | ||
| Q2 25 | 23.1% | -6.9% | ||
| Q1 25 | 14.4% | -27.4% | ||
| Q4 24 | 9.7% | -13.5% | ||
| Q3 24 | 3.8% | -13.9% | ||
| Q2 24 | 9.3% | -16.8% | ||
| Q1 24 | 7.4% | -19.1% |
每股收益（稀释后）HRTGOFIX
| Q4 25 | $2.15 | $-0.05 | ||
| Q3 25 | $1.63 | $-0.57 | ||
| Q2 25 | $1.55 | $-0.36 | ||
| Q1 25 | $0.99 | $-1.35 | ||
| Q4 24 | $0.66 | $-0.76 | ||
| Q3 24 | $0.27 | $-0.71 | ||
| Q2 24 | $0.61 | $-0.88 | ||
| Q1 24 | $0.47 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $559.3M | $82.0M |
| 总债务越低越好 | $78.4M | — |
| 股东权益账面价值 | $505.3M | $450.0M |
| 总资产 | $2.2B | $850.6M |
| 负债/权益比越低杠杆越低 | 0.16× | — |
8季度趋势，按日历期对齐
现金及短期投资HRTGOFIX
| Q4 25 | $559.3M | $82.0M | ||
| Q3 25 | $560.4M | $62.9M | ||
| Q2 25 | $473.5M | $65.6M | ||
| Q1 25 | $425.9M | $58.0M | ||
| Q4 24 | $452.7M | $83.2M | ||
| Q3 24 | $509.9M | $30.1M | ||
| Q2 24 | $480.9M | $26.4M | ||
| Q1 24 | $386.1M | $27.0M |
总债务HRTGOFIX
| Q4 25 | $78.4M | — | ||
| Q3 25 | $79.3M | $157.2M | ||
| Q2 25 | $92.4M | $157.0M | ||
| Q1 25 | $94.8M | $156.9M | ||
| Q4 24 | $116.3M | $157.0M | ||
| Q3 24 | $118.6M | $118.5M | ||
| Q2 24 | $120.8M | $118.0M | ||
| Q1 24 | $123.0M | $118.2M |
股东权益HRTGOFIX
| Q4 25 | $505.3M | $450.0M | ||
| Q3 25 | $437.3M | $442.5M | ||
| Q2 25 | $383.3M | $458.3M | ||
| Q1 25 | $329.0M | $458.3M | ||
| Q4 24 | $290.8M | $503.1M | ||
| Q3 24 | $279.3M | $525.9M | ||
| Q2 24 | $255.3M | $546.0M | ||
| Q1 24 | $234.9M | $570.3M |
总资产HRTGOFIX
| Q4 25 | $2.2B | $850.6M | ||
| Q3 25 | $2.4B | $832.6M | ||
| Q2 25 | $2.5B | $837.2M | ||
| Q1 25 | $2.2B | $823.1M | ||
| Q4 24 | $2.5B | $893.3M | ||
| Q3 24 | $2.4B | $867.9M | ||
| Q2 24 | $2.6B | $882.0M | ||
| Q1 24 | $2.1B | $906.0M |
负债/权益比HRTGOFIX
| Q4 25 | 0.16× | — | ||
| Q3 25 | 0.18× | 0.36× | ||
| Q2 25 | 0.24× | 0.34× | ||
| Q1 25 | 0.29× | 0.34× | ||
| Q4 24 | 0.40× | 0.31× | ||
| Q3 24 | 0.42× | 0.23× | ||
| Q2 24 | 0.47× | 0.22× | ||
| Q1 24 | 0.52× | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $182.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $174.2M | $16.8M |
| 自由现金流率自由现金流/营收 | 80.9% | 7.6% |
| 资本支出强度资本支出/营收 | 3.7% | 4.9% |
| 现金转化率经营现金流/净利润 | 2.73× | — |
| 过去12个月自由现金流最近4个季度 | $337.4M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HRTGOFIX
| Q4 25 | $182.2M | $27.7M | ||
| Q3 25 | $124.3M | $12.4M | ||
| Q2 25 | $43.3M | $11.6M | ||
| Q1 25 | $837.0K | $-18.4M | ||
| Q4 24 | $87.1M | $23.7M | ||
| Q3 24 | $-13.4M | $11.7M | ||
| Q2 24 | $152.2M | $9.0M | ||
| Q1 24 | $4.3M | $-18.6M |
自由现金流HRTGOFIX
| Q4 25 | $174.2M | $16.8M | ||
| Q3 25 | $122.7M | $2.5M | ||
| Q2 25 | $41.8M | $4.5M | ||
| Q1 25 | $-1.3M | $-25.1M | ||
| Q4 24 | $78.9M | $15.2M | ||
| Q3 24 | $-16.3M | $6.3M | ||
| Q2 24 | $149.8M | $-360.0K | ||
| Q1 24 | $4.1M | $-29.1M |
自由现金流率HRTGOFIX
| Q4 25 | 80.9% | 7.6% | ||
| Q3 25 | 57.8% | 1.2% | ||
| Q2 25 | 20.1% | 2.2% | ||
| Q1 25 | -0.6% | -13.0% | ||
| Q4 24 | 37.5% | 7.0% | ||
| Q3 24 | -7.7% | 3.2% | ||
| Q2 24 | 73.6% | -0.2% | ||
| Q1 24 | 2.1% | -15.4% |
资本支出强度HRTGOFIX
| Q4 25 | 3.7% | 4.9% | ||
| Q3 25 | 0.7% | 4.8% | ||
| Q2 25 | 0.7% | 3.5% | ||
| Q1 25 | 1.0% | 3.5% | ||
| Q4 24 | 3.9% | 4.0% | ||
| Q3 24 | 1.4% | 2.7% | ||
| Q2 24 | 1.2% | 4.7% | ||
| Q1 24 | 0.1% | 5.6% |
现金转化率HRTGOFIX
| Q4 25 | 2.73× | — | ||
| Q3 25 | 2.47× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 4.29× | — | ||
| Q3 24 | -1.64× | — | ||
| Q2 24 | 8.07× | — | ||
| Q1 24 | 0.30× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRTG
暂无分部数据
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
